||EPS - Basic
||Market Cap (m)
|Technology Hardware & Equipment
|nod: The cost to shareholders of a name change and share price consolidation must be a lot greater than the cost of moving its registered office from Grand Cayman to the United Kingdom.A name change has an impact on all customers and their accounts. It involves rebranding of stationery, logos, web site, stock market listing, directories, etc. I went through this a few years ago and the logo change alone cost tens of thousands, with all the material and printing that needs to be changed. Many things people don't think about. The execs don't come across to me as good planners who can do this project in their spare time.The consolidation will inevitably lead to a falling share price as FSTG will be viewed as expensive given the size of revenue and profits. This process will also cost money without adding any value.|
|chillpill: When they have revenue and profits to base a valuation it doesn't make much difference.
You value a share on market cap/ enterprise value not a share price.|
|krr13: The share consolidation should help to reduce big swings in share price and market cap. Change of name is absolutely appropriate given the disposal of healthcare (which should have been done sooner). The figures show that things are on the turn and are heading in the right direction.|
|sabre6: I think we are on the cusp of a share price rise as I stated several weeks ago the share price was showing signs of a rise and wanting to go higher.
I reckon this could go to 13p + over the next couple of years|
|sabre6: Unfortunately the share price says it all|
|sabre6: By the sounds of it the NHS is not going to get the funding promised by the vote out campaigners so I think even if trials are successful for sensium it will be put on the back shelf by the NHS.
We can only hope it is taken up abroad.
Cash generating does not mean being in profit. The share price has been sliding over the months and at the moment I can`t see anything stopping the slide.|
|sabre6: I would not hold your breath I think the share price says it all!|
|sabre6: This share was supposed to generate cash by the middle of this year!
Not according to the share price.|
|birkenhead: One hopes Prof T doesn’t get another unmerited extension without giving us a large slice of his tasty-looking DNA pie to make up for him leaving us holding his abandoned baby’s soiled nappies:
“Toumaz Limited (AIM: TMZ) announces that on 29(th) September 2015, the Company's Board of Directors has formalised an undertaking made by the previous Board that 1,683,835 fully vested options with an exercise price of 6.94p granted to Prof C Toumazou on 30 September 2005 and due to expire on 30 September 2015 have been extended by 12 months to expire on 30 September 2016.”
Also, it would be jolly nice if Mr. Sethill could mumble a bit more positively about achievable PROFIT (not cash flow Newspeak!) targets and exactly how he is going to maximise shareholder returns (after demolishing the share price from 12p to 2p) to justify his & Mr. App’s lavish share options:
“the Group is expected to be cash-flow generative in mid-2016.” (21.1.16)
"We expect the Group to be cash flow break-even by the middle of 2016." (22.3.16)|
|birkenhead: TD, why? Do you have any opinions to add? Please note that I did wink & am still a long-suffering (but optimistic) TMZ shareholder. My main gripe is two people hogging most of the options and setting a ridiculously low share price target after decimating it by failing to deliver anything. However, having met IMG's Sir HY at an AGM, I am prepared to be excruciatingly patient with IMG and TMZ - for what little my opinions are worth!|
Toumaz share price data is direct from the London Stock Exchange